ENX-104 MAD Study for Participants With Major Depressive Disorder With Anhedonia (aMDD)

NCT07253324 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: ENX-104
DRUG: Placebo

Sponsor

Engrail Therapeutics INC